Similar Articles
161 Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
162 Zinc finger E-box-binding homeobox 1 mediates aerobic glycolysis via suppression of sirtuin 3 in pancreatic cancer
163 Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer
164 Typing of pancreatic cancer-associated fibroblasts identifies different subpopulations
165 Current role of palliative interventions in advanced pancreatic cancer
166 Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma
167 Time to think: Selecting patients who may benefit from synchronous resection of primary pancreatic cancer and liver metastases
168 p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation
169 Shattering the castle walls: Anti-stromal therapy for pancreatic cancer
170 Stage III should be subclassified into Stage IIIA and IIIB in the American Joint Committee on Cancer (8th Edition) staging system for pancreatic cancer
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA